Related Experiment Videos
A robust summarize-regress procedure for tissue-specific pharmacokinetics.
1Kansas Cancer Institute, University of Kansas Medical Center, Kansas City 66160-7312, USA.
Journal of Biopharmaceutical Statistics
|May 10, 2000
Summary
This study recommends using the median instead of the average percent injected dose per gram (PID) for modeling radiolabeled ligand pharmacokinetics. This median approach improves accuracy in time-dependent pharmacokinetic models derived from destructive sampling in animal studies.
Area of Science:
- Pharmacokinetics
- Radiopharmaceutical Science
- Biomedical Research
Background:
- Tissue-specific pharmacokinetic analysis of radiolabeled ligands often requires destructive sampling.
- Current methods use average percent injected dose per gram (PID) at sacrifice time points, limiting true time-dependent model estimation.
Purpose of the Study:
- To propose and evaluate the median as a more robust summary measure than the average for PID in pharmacokinetic modeling.
- To compare the performance of median-based versus average-based modeling using experimental data and simulations.
Main Methods:
- Destructive sampling in animal models to obtain tissue-specific radiolabeled ligand data.
- Summarizing percent injected dose per gram (PID) at various time points.
- Modeling using both average PID and median PID, followed by comparative analysis.
Main Results:
- Demonstrated discrepancy between modeling average PID and median PID through an actual experiment.
- Simulation studies indicated differences in parameter estimation when using average versus median PID.
Conclusions:
- The median is recommended as the superior summary measure for modeling PID in time-dependent pharmacokinetic studies with destructive sampling.
- Using median PID can lead to more accurate pharmacokinetic parameter estimation compared to average PID.